vs

Side-by-side financial comparison of Clorox (CLX) and IDEX Corporation (IEX). Click either name above to swap in a different company.

Clorox is the larger business by last-quarter revenue ($1.7B vs $886.9M, roughly 1.9× IDEX Corporation). IDEX Corporation runs the higher net margin — 13.5% vs 9.4%, a 4.1% gap on every dollar of revenue. On growth, IDEX Corporation posted the faster year-over-year revenue change (8.9% vs 0.3%). Over the past eight quarters, IDEX Corporation's revenue compounded faster (5.4% CAGR vs -8.3%).

The Clorox Company is an American multinational manufacturer and marketer of consumer and professional products. Clorox ranked annually on the Fortune 500 list from 2000 to 2024, where it last held the #485 spot.

IDEX can refer to several things, including:International Defence Exhibition, a biennial arms and defense technology sales exhibition IDEX Corporation, a publicly listed company that makes fluidics systems and specialty engineered products Ideanomics, a publicly traded company that trades under the IDEX ticker symbol.

CLX vs IEX — Head-to-Head

Bigger by revenue
CLX
CLX
1.9× larger
CLX
$1.7B
$886.9M
IEX
Growing faster (revenue YoY)
IEX
IEX
+8.6% gap
IEX
8.9%
0.3%
CLX
Higher net margin
IEX
IEX
4.1% more per $
IEX
13.5%
9.4%
CLX
Faster 2-yr revenue CAGR
IEX
IEX
Annualised
IEX
5.4%
-8.3%
CLX

Income Statement — Q2 FY2026 vs Q2 FY2026

Metric
CLX
CLX
IEX
IEX
Revenue
$1.7B
$886.9M
Net Profit
$157.0M
$120.0M
Gross Margin
43.2%
44.9%
Operating Margin
19.4%
Net Margin
9.4%
13.5%
Revenue YoY
0.3%
8.9%
Net Profit YoY
-15.6%
25.7%
EPS (diluted)
$1.29
$1.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLX
CLX
IEX
IEX
Q2 26
$886.9M
Q1 26
$899.1M
Q4 25
$1.7B
$899.1M
Q3 25
$878.7M
Q2 25
$2.0B
$865.4M
Q1 25
$1.7B
$814.3M
Q4 24
$1.7B
$862.9M
Q3 24
$1.8B
$798.2M
Net Profit
CLX
CLX
IEX
IEX
Q2 26
$120.0M
Q1 26
$128.3M
Q4 25
$157.0M
$128.3M
Q3 25
$127.8M
Q2 25
$332.0M
$131.6M
Q1 25
$186.0M
$95.5M
Q4 24
$193.0M
$123.2M
Q3 24
$99.0M
$119.1M
Gross Margin
CLX
CLX
IEX
IEX
Q2 26
44.9%
Q1 26
43.1%
Q4 25
43.2%
43.1%
Q3 25
44.5%
Q2 25
46.5%
45.3%
Q1 25
44.6%
45.3%
Q4 24
43.8%
42.5%
Q3 24
45.8%
44.3%
Operating Margin
CLX
CLX
IEX
IEX
Q2 26
19.4%
Q1 26
20.4%
Q4 25
20.4%
Q3 25
21.1%
Q2 25
20.6%
21.7%
Q1 25
15.2%
17.4%
Q4 24
14.1%
19.2%
Q3 24
10.0%
21.0%
Net Margin
CLX
CLX
IEX
IEX
Q2 26
13.5%
Q1 26
14.3%
Q4 25
9.4%
14.3%
Q3 25
14.5%
Q2 25
16.7%
15.2%
Q1 25
11.2%
11.7%
Q4 24
11.4%
14.3%
Q3 24
5.6%
14.9%
EPS (diluted)
CLX
CLX
IEX
IEX
Q2 26
$1.61
Q1 26
$1.71
Q4 25
$1.29
$1.71
Q3 25
$1.70
Q2 25
$2.68
$1.74
Q1 25
$1.50
$1.26
Q4 24
$1.54
$1.61
Q3 24
$0.80
$1.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLX
CLX
IEX
IEX
Cash + ST InvestmentsLiquidity on hand
$227.0M
$586.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$-125.0M
$4.0B
Total Assets
$5.6B
$6.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLX
CLX
IEX
IEX
Q2 26
$586.2M
Q1 26
$580.0M
Q4 25
$227.0M
$580.0M
Q3 25
$593.8M
Q2 25
$167.0M
$568.2M
Q1 25
$226.0M
$594.1M
Q4 24
$290.0M
$620.8M
Q3 24
$278.0M
$633.2M
Total Debt
CLX
CLX
IEX
IEX
Q2 26
Q1 26
Q4 25
$1.8B
Q3 25
$1.9B
Q2 25
$2.5B
$1.9B
Q1 25
$2.0B
Q4 24
$2.0B
Q3 24
$2.1B
Stockholders' Equity
CLX
CLX
IEX
IEX
Q2 26
$4.0B
Q1 26
$4.0B
Q4 25
$-125.0M
$4.0B
Q3 25
$4.0B
Q2 25
$321.0M
$4.0B
Q1 25
$27.0M
$3.9B
Q4 24
$-41.0M
$3.8B
Q3 24
$60.0M
$3.8B
Total Assets
CLX
CLX
IEX
IEX
Q2 26
$6.9B
Q1 26
$6.9B
Q4 25
$5.6B
$6.9B
Q3 25
$7.0B
Q2 25
$5.6B
$6.9B
Q1 25
$5.5B
$6.8B
Q4 24
$5.6B
$6.7B
Q3 24
$5.5B
$7.0B
Debt / Equity
CLX
CLX
IEX
IEX
Q2 26
Q1 26
Q4 25
0.45×
Q3 25
0.48×
Q2 25
7.74×
0.46×
Q1 25
0.50×
Q4 24
0.52×
Q3 24
0.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLX
CLX
IEX
IEX
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$86.0M
FCF MarginFCF / Revenue
9.7%
Capex IntensityCapex / Revenue
2.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$654.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLX
CLX
IEX
IEX
Q2 26
Q1 26
Q4 25
$209.5M
Q3 25
$203.5M
Q2 25
$294.0M
$161.7M
Q1 25
$286.0M
$105.7M
Q4 24
$180.0M
$172.6M
Q3 24
$221.0M
$205.3M
Free Cash Flow
CLX
CLX
IEX
IEX
Q2 26
$86.0M
Q1 26
$189.8M
Q4 25
$189.8M
Q3 25
$188.7M
Q2 25
$219.0M
$146.9M
Q1 25
$233.0M
$91.4M
Q4 24
$127.0M
$157.1M
Q3 24
$182.0M
$191.6M
FCF Margin
CLX
CLX
IEX
IEX
Q2 26
9.7%
Q1 26
21.1%
Q4 25
21.1%
Q3 25
21.5%
Q2 25
11.0%
17.0%
Q1 25
14.0%
11.2%
Q4 24
7.5%
18.2%
Q3 24
10.3%
24.0%
Capex Intensity
CLX
CLX
IEX
IEX
Q2 26
2.0%
Q1 26
7.1%
Q4 25
2.2%
Q3 25
1.7%
Q2 25
3.8%
1.7%
Q1 25
3.2%
1.8%
Q4 24
3.1%
1.8%
Q3 24
2.2%
1.7%
Cash Conversion
CLX
CLX
IEX
IEX
Q2 26
Q1 26
Q4 25
1.63×
Q3 25
1.59×
Q2 25
0.89×
1.23×
Q1 25
1.54×
1.11×
Q4 24
0.93×
1.40×
Q3 24
2.23×
1.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLX
CLX

Health And Wellness$643.0M38%
Household$419.0M25%
Lifestyle$321.0M19%
Other$290.0M17%

IEX
IEX

Segment breakdown not available.

Related Comparisons